Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled study of BIOS-0618 for excessive daytime sleepiness in obstructive sleep apnea
CTR20252426Phase 2Active
- Sponsor
- 百诚医药
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of BIOS-0618 in obstructive sleep apnea hypopnea syndrome (OSAHS), sponsored by 百诚医药. Started Aug 2025; status: active.
02
Drugs
BIOS-0618
03
Conditions
obstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on CTR20252426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20252426.